Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
Running, not enrolling · Phase 2
Conditions studied: Synovial Sarcoma, Myxoid Liposarcoma
In brief
This is a study to investigate the efficacy and safety of ADP-A2M4 in HLA-A\*02 eligible and MAGE-A4 positive subjects with metastatic or inoperable (advanced) Synovial Sarcoma (Cohort 1, 2 and 3 ) or MRCLS (Cohort 1) .
Key facts
- Study ID
- NCT04044768
- Run by
- USWM CT, LLC
- People needed
- 52
- Starts
- 2019-08-13
- Expected to finish
- 2038-04-01
- Last updated by the study team
- 2026-02-06
Who can join
Age: 10 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- City of Hope — Duarte, California, United States
- Stanford Cancer Center — Palo Alto, California, United States
- University of Colorado — Aurora, Colorado, United States
- Mayo Clinic Jacksonville — Jacksonville, Florida, United States
- Moffitt Cancer Center — Tampa, Florida, United States
- Northwestern University Robert H. Lurie Comprehensive Cancer Center — Chicago, Illinois, United States
- National Cancer Institute — Bethesda, Maryland, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Dana Farber Cancer Institute — Boston, Massachusetts, United States
- University of Michigan — Ann Arbor, Michigan, United States
- Washington University School of Medicine — St Louis, Missouri, United States
- Memorial Sloan-Kettering Cancer Center — New York, New York, United States
- Ohio State University — Columbus, Ohio, United States
- Vanderbilt — Nashville, Tennessee, United States
- MD Anderson Cancer Center — Houston, Texas, United States
- Fred Hutch — Seattle, Washington, United States
- Medical College of WI Froedtert Hospital — Milwaukee, Wisconsin, United States
- Princess Margaret Cancer Centre — Toronto, Ontario, Canada
- Centre Leon Berard — Lyon, France
- Hospital Haut Leveque, CHU Bordeaux — Pessac, France
- Gustave Roussy Cancer Center — Villejuif, France
- Hospital Universitari Vall D'Hebron — Barcelona, Catalonia, Spain
- Start Madrid-FJD, Fundación Jimѐnez Díaz — Madrid, Spain
- Hospital Universitario Virgen del Rocio — Seville, Spain
- UCLH Cancer Clinical Trials Unit — London, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.